VeriMomdibromopropamidine diisethionate hamilelikte güvenli mi?
No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
Related ingredients
Frequently asked questions
- dibromopropamidine diisethionate hamilelikte güvenli mi?
- No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
- dibromopropamidine diisethionate emzirirken güvenli mi?
- No evidence of reproductive or developmental hazard or mechanism specific to this compound was found. Because topical/ophthalmic use leads to low but measurable systemic exposure, a low exposure score is assigned for lactation; no data on milk transfer were located. Sources: PubChem entry, product/labeling references indicating topical ophthalmic use; no PubMed studies on lactation or milk transfer were found.
- dibromopropamidine diisethionate bebek cildi için güvenli mi?
- No infant-specific reproductive or mechanistic evidence was found. The ingredient is used in topical/ophthalmic products (including products for children in some markets), and immature infant skin has higher per‑kg exposure; therefore exposure is scored one category higher than adult topical use. No data were found showing increased hazard or specific infant toxicity. Sources: product/medicinal listings showing pediatric topical/ophthalmic use and pharmacopoeial references; absence of reproductive/toxicity studies in PubMed.
- VeriMom dibromopropamidine diisethionate nasıl puanlıyor?
- VeriMom dibromopropamidine diisethionate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte dibromopropamidine diisethionate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.